E. coli-synthesized selenium nanoparticles suppress phoP and bapA gene expression in S. enterica isolated from human blood
DOI:
https://doi.org/10.3855/jidc.22789Keywords:
selenium, nanoparticles, E. coli, Salmonella, phoP gene, bapA geneAbstract
Introduction: Typhoid fever is caused by Salmonella enterica, which is a chronic health problem in endemic areas due to multidrug resistance and biofilm development. The stress adaptation and virulence regulatory gene phoP and the biofilm-associated gene bapA may represent molecular targets for anti-virulence interventions. In this study, S. Typhi isolates from blood samples were characterized for their antimicrobial sensitivity and biofilm formation, and the molecular impact of biosynthesized selenium nanoparticles (SeNPs) on phoP and bapA expression was assessed.
Methodology: Biochemical analyses and 16S rRNA polymerase chain reaction (PCR) were performed on 92 blood samples identified 35 S. Typhi isolates. Antimicrobial susceptibility was evaluated by standard protocols. Biofilm-formation capacity was determined. SeNPs were obtained from E. coli by biological synthesis according to ultraviolet–visible (UV-vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) analyses; at concentrations of 12.5–100 µg/mL. Differences in gene expression were quantified by quantitative reverse transcription real-time PCR.
Results: All the isolates were resistant to ampicillin and ceftriaxone; susceptible to meropenem, ertapenem, trimethoprim–sulfamethoxazole, chloramphenicol, and tetracycline; and had variable sensitivity to ciprofloxacin. The isolates induced strong (57.1%) and moderate (40%) biofilm formation. The production of phoP and bapA were significantly inhibited by SeNPs treatment in a concentration-dependent manner, with maximal inhibition at 100 µg/mL (p = 0.0001); and exhibited a significant positive correlation for both genes (R = 0.899).
Conclusions: Biosynthesized SeNPs effectively downregulate key virulence determinants in antibiotic-resistant S. Typhi, supporting their potential as adjunctive or alternative therapies capable of decelerating pathogenicity and biofilm-associated persistence.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sarab Murad Kadhem , Nawal Jasim Shanyoor, Zainab Fayadh Shubrem, Huda Abbas Abd

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

